The Case for Computational Reasoning in Precision Oncology

By: Alina Luchian and Dr. Istvan Petak, Founder and CSO – Genomate Health

Precision oncology has long promised to revolutionize cancer treatment by tailoring therapies to each tumor’s unique genetic profile. Yet more than a decade into this approach, results have been mixed. While some patients have seen dramatic benefits from targeted drugs, overall cancer mortality hasn’t shifted as much as hoped.